Comparison of Two Kidney Drainage Tube Placement Methods after Percutaneous Nephrolithotomy: Balloon (with Traction) versus Conventional Method, in Terms of Anemia Severity in Patients with a Solitary Pelvic Stone

Comparison of the Effectiveness of Balloon Traction Nephrostomy versus Conventional Nephrostomy Placement in Reducing Hemoglobin Drop in Patients with a Solitary Pelvic Stone Undergoing Percutaneous Nephrolithotomy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200825048515N88

Enrollment

130

Registered

2026-05-03

Start date

2026-06-21

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a Solitary Pelvic Stone Undergoing Percutaneous Nephrolithotomy. Calculus of kidney

Interventions

Intervention 1: Intervention group: At the end of the percutaneous nephrolithotomy (PCNL) procedure, patients will receive a balloon nephrostomy tube placed into the urinary collecting system. This tu

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with a Solitary Pelvic Stone Undergoing Percutaneous Nephrolithotomy Age group 18 years and older

Exclusion criteria

Exclusion criteria: History of anticoagulant use or having uncorrected coagulopathy disorders History of renal failure History of untreated urinary tract infection History of severe pre-existing anemia History of flank surgery (e.g., nephrolithotomy, pyeloplasty, ureterolithotomy, pyelolithotomy, etc.) Patients with a solitary kidney (due to compensatory hypertrophy or possible chronic kidney disease (CKD), the risk of bleeding is higher and acts as a confounder) History of renal anomalies such as horseshoe kidney and nephroptosis History of vascular diseases Patients who required angioembolization during a previous PCNL

Design outcomes

Primary

Measure	Time frame
Hemoglobin. Timepoint: Before and after intervention. Method of measurement: Blood test.;Hematocrit. Timepoint: Before and after intervention. Method of measurement: Blood test.;Hydronephrosis. Timepoint: One week after the intervention. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Kazemi

Esfahan University of Medical Sciences

Rezakazemi6788@gmail.com+98 31 3222 2127

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026